|
|
|
Insider
Information: |
Sing George L |
Relationship: |
Director |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
27,472 |
|
Indirect Shares
|
2,150 |
|
|
Direct
Value |
$27,060,469 |
|
|
Indirect Value
|
$2,117,793 |
|
|
Total
Shares |
29,622 |
|
|
Total
Value |
$29,178,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
34
|
Stock
price went up :
|
0
|
17
|
Stock
price went down : |
0
|
17
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
3.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-05-03 |
27,472 |
2024-05-03 |
2,150 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-05-13 |
4 |
OE |
$33.42 |
$167,100 |
D/D |
5,000 |
120,415 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-05-28 |
4 |
S |
$578.00 |
$579,000 |
I/I |
(1,000) |
8,200 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-05-29 |
4 |
S |
$595.00 |
$596,510 |
I/I |
(1,000) |
7,700 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-06-29 |
4 |
AS |
$606.80 |
$1,826,721 |
I/I |
(3,000) |
6,200 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-07-07 |
4 |
AS |
$650.00 |
$1,950,474 |
I/I |
(3,000) |
4,700 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-07-07 |
4 |
AS |
$650.00 |
$4,875,000 |
D/D |
(7,500) |
115,415 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-07-07 |
4 |
OE |
$33.42 |
$250,650 |
D/D |
7,500 |
122,915 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-20 |
4 |
OE |
$57.11 |
$571,100 |
D/D |
10,000 |
114,415 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-20 |
4 |
S |
$615.48 |
$12,955,042 |
D/D |
(21,000) |
104,415 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-21 |
4 |
S |
$605.04 |
$12,080,040 |
D/D |
(19,963) |
94,415 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-21 |
4 |
OE |
$57.11 |
$1,168,071 |
D/D |
9,963 |
114,078 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-24 |
4 |
OE |
$177.82 |
$1,784,779 |
D/D |
10,037 |
104,452 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-24 |
4 |
S |
$592.27 |
$11,894,577 |
D/D |
(20,037) |
84,415 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-25 |
4 |
OE |
$273.67 |
$3,489,293 |
D/D |
12,750 |
97,165 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-25 |
4 |
S |
$600.36 |
$19,888,518 |
D/D |
(32,750) |
64,415 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-25 |
4 |
S |
$612.00 |
$612,000 |
I/I |
(1,000) |
3,700 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2020-08-31 |
4 |
S |
$610.45 |
$6,120,555 |
D/D |
(10,000) |
54,415 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
54,663 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-08-06 |
4 |
S |
$611.23 |
$2,445,520 |
D/D |
(4,000) |
50,663 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-08-06 |
4 |
S |
$612.42 |
$214,347 |
I/I |
(350) |
3,350 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-08-10 |
4 |
S |
$613.01 |
$1,596,010 |
D/D |
(2,600) |
48,063 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-08-11 |
4 |
S |
$620.00 |
$186,000 |
I/I |
(300) |
3,050 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-08-11 |
4 |
S |
$620.00 |
$1,241,000 |
D/D |
(2,000) |
46,063 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-08-12 |
4 |
S |
$611.00 |
$611,000 |
D/D |
(1,000) |
45,063 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2021-08-13 |
4 |
S |
$620.00 |
$310,000 |
D/D |
(500) |
44,563 |
0 |
% |
|
100 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|